McMullin David 4
4 · Aldeyra Therapeutics, Inc. · Filed Sep 9, 2019
Insider Transaction Report
Form 4
McMullin David
SVP Corp. Dev. & Strategy
Transactions
- Purchase
Common Stock
2019-09-05$4.68/sh+4,329$20,260→ 6,148 total
Footnotes (1)
- [F1]Includes 1,819 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan (ESPP) in 2019.